Pathogenesis of Alcoholic Liver Disease

Area of Science:

• Hepatology
• Immunology
• Gastroenterology

Background:

• Alcoholic liver disease (ALD) presents a spectrum of conditions, including steatosis, cirrhosis, and hepatocellular carcinoma.
• ALD pathogenesis involves ethanol toxicity, immune responses, and gut microbiome alterations.

Purpose of the Study:

• To review the clinical-histological spectrum of alcoholic liver disease.
• To discuss the pathogenesis of ALD, focusing on ethanol injury, immune response, and gut microbiome.
• To explore current and emerging therapeutic strategies for ALD.

Main Methods:

• Literature review of ALD pathogenesis and treatment.
• Analysis of the role of inflammation and gut permeability in ALD.
• Evaluation of existing and novel therapeutic interventions.

Main Results:

• ALD pathogenesis is multifactorial, involving direct ethanol effects, inflammation, and dysbiosis.
• Corticosteroids show controversial short-term benefits.
• Emerging therapies targeting pathophysiology include antibiotics, anti-inflammatories, and FXR agonists.

Conclusions:

• ALD requires a comprehensive understanding of its complex pathogenesis.
• Novel therapies targeting specific pathways hold promise for improved ALD management.
• Further research is crucial for developing effective treatments for this challenging disease.